Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Stressgen Cuts Staff, Saving Resources For HPV Vaccine

April 29, 2005

By Jennifer Boggs

Penwest's Beta-Blocker PW2101 Subject Of Prism Marketing Deal

April 28, 2005

By Jennifer Boggs

Penwest's Beta-Blocker PW2101 Subject Of Prism Marketing Deal

April 28, 2005

By Jennifer Boggs

OncoGenex In-Licenses Hsp27 Inhibitors For Isis Collaboration

April 27, 2005

By Jennifer Boggs

OncoGenex In-Licenses Hsp27 Inhibitors For Isis Collaboration

April 27, 2005

By Jennifer Boggs

Prestwick Seeks $75M IPO, Readies Tetrabenazine NDA

April 26, 2005

By Jennifer Boggs

Prestwick Seeks $75M IPO, Readies Tetrabenazine NDA

April 26, 2005

By Jennifer Boggs

Hamilton Pharmaceuticals' First Financing: $11M For CNS Drugs

April 25, 2005

By Jennifer Boggs

Hamilton Pharmaceuticals' First Financing: $11M For CNS Drugs

April 25, 2005

By Jennifer Boggs

Genzyme Beats Consensus, Increases Full-Year Guidance

April 22, 2005

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...